Real-world monitoring of platelet counts among patients with epithelial ovarian cancer receiving first-line maintenance niraparib in the United States: the ACTIV1ZE study

被引：0
|
作者：
Musa, Fernanda [1 ]
Boyle, Tirza [2 ]
Lim, Jonathan [2 ]
Moore, Julia [2 ]
Schilder, Jeanne [3 ]
Hurteau, Jean [4 ]
Golembesky, Amanda [5 ]
Landrum, Lisa [6 ]
机构：
[1] Swedish Canc Inst, Seattle, WA USA
[2] GSK, Upper Providence, PA USA
[3] GSK, Philadelphia, PA USA
[4] GSK, Waltham, MA USA
[5] GSK, Durham, NC USA
[6] Indiana Univ, Hlth Simon Canc Ctr, Indianapolis, IN USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.74
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PR032/#594
引用
收藏
页码：A56 / A57
页数：2
相关论文
共 50 条
  • [21] Real-world patterns and predictors of first-line maintenance use among patients with newly diagnosed advanced ovarian cancer: Is there an opportunity for change?
    Liu, Jinan
    Thaker, Premal H.
    Sah, Janvi
    Maiese, Eric M.
    Bee, Oscar
    Hurteau, Jean
    Chan, John
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [22] Reasons for first-line maintenance therapy discontinuation among patients with newly diagnosed advanced ovarian cancer treated in real-world settings
    Liu, Jinan
    Thaker, Premal H.
    Sah, Janvi
    Maiese, Eric M.
    Kalilani, Linda
    Mallampati, Rajesh
    Hurteau, Jean
    Chan, John
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [23] Real-world patterns and predictors of first-line maintenance use among patients with newly diagnosed advanced ovarian cancer: Is there an opportunity for change?
    Liu, Jinan
    Thaker, Premal H.
    Sah, Janvi
    Maiese, Eric M.
    Bee, Oscar
    Hurteau, Jean
    Chan, John
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [24] Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States
    Moon, Helen H.
    Kearney, Mairead
    Mahmoudpour, Seyed Hamidreza
    Ike, Chiemeka
    Morris, Valerie
    Rava, Andrew
    Kim, Sonia
    Sun, Haiyan
    Boyd, Marley
    Gomez Rey, Gabriel
    CURRENT ONCOLOGY, 2024, 31 (09) : 5662 - 5676
  • [25] First-line rucaparib maintenance after hyperthermic intraperitoneal chemotherapy with interval debulking surgery for advanced epithelial ovarian cancer: a real-world study
    Palo, Upasana
    Mondal, Debapriya
    Ghosh, Anik
    Chakraborti, Basumita
    Roy, Somnath
    Bhaumik, Jaydip
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A242 - A242
  • [26] REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH METASTATIC RENAL CELL CARCINOMA RECEIVING FIRST-LINE THERAPY IN THE UNITED STATES VETERAN POPULATION
    Bhanegaonkar, A.
    Kim, R.
    Pandya, S.
    Wang, L.
    Krulewicz, S.
    Pennock, G.
    Phatak, H.
    VALUE IN HEALTH, 2019, 22 : S116 - S116
  • [27] Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study
    Rimel, Bobbie
    Boyle, Tirza Areli Calderon
    Burns, Sara
    Lim, Jonathan
    Hartman, John
    Kalilani, Linda
    Schilder, Jeanne M.
    Hurteau, Jean A.
    Golembesky, Amanda
    ONCOLOGY AND THERAPY, 2024, 12 (03) : 465 - 475
  • [28] The potential impact of excluding patients with stage III epithelial ovarian cancer and no postoperative visible residual disease from the PRIMA/ENGOT-OV26/GOG-3012 trial: The AR1ZE real-world study of niraparib first-line maintenance therapy
    Chase, Dana
    Hanna, Maya
    Lim, Jonathan
    Boyle, Tirza Areli Calderon
    Guinter, Mark
    Richey, Madeline
    Patel, Khilna
    Schilder, Jeanne
    Hurteau, Jean
    Golembesky, Amanda
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S215 - S216
  • [29] The real-world use of first-line maintenance treatment regimens among patients with advanced ovarian cancer varies by biomarker status: results from the Europa study
    Fagotti, Anna
    Braicu, Elena
    Frenel, Jean-Sebastien
    Saint-Ghislain, Mathilde
    Wirtz, Marina
    Lim, Jonathan
    Boyle, Tirza
    Mascialino, Barbara
    Arnold, Kellyn
    Chaparova, Elena
    Hogg, Catherine
    Golembesky, Amanda
    Scambia, Giovanni
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A211 - A212
  • [30] Real world clinical outcomes of niraparib first line maintenance therapy in patients with BRCA wildtype advanced ovarian cancer
    Piedimonte, Sabrina
    Clarfield, Lauren
    Manley, Mollie
    Kupets, Rachel
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A325 - A325
12345